Public and corporate affairs agency Hume Brophy has launched a new life sciences arm to its international healthcare business.
Hume Brophy Life Sciences will provide a targeted approach to healthcare communications and further help their clients navigate “highly-regulated complexities of the vibrant life science market across Europe”.
Drawing in ‘experts’ from across the medical communications, science, academia, media, pharma and biotech fields, the team will develop and deliver advocacy platforms, strategic communications and market planning programmes.
The new practice will be led by Hume Brophy International Healthcare’s managing director Conor Griffin.
He said: “In an increasingly competitive, fast-changing and cost-sensitive healthcare industry we have put together a multidisciplinary team of science, media, regulatory and policy experts that can translate the complex challenges facing healthcare innovators into tailored strategic communication programmes to highlight the often unmet needs for an increasingly demanding society.”
The practice will operate from all Hume Brophy offices, including London, Brussels, Dublin, New York, Paris, Hong Kong and Singapore.